| Analysis | Metabolite Name | Measured Value | Units | Sex | Severity_Scale | Race | Ethnicity | hasSmokingBeforeCOVID-19 | Time |
|---|---|---|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.996785042 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.780342254 | log transformed data | Female | 2 | Other | Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.770440571 | log transformed data | Female | 2 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.665835813 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.656258435 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.606465632 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.573318541 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.572809751 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.564240768 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.534615422 | log transformed data | Male | 3 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.524395687 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.517101645 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.455004865 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.447661159 | log transformed data | Female | 1 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.445377628 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.433089177 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.430922942 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.422316695 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.416292035 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.414650136 | log transformed data | Female | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.413364623 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.406654385 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.400484903 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.399550537 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.380611116 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.370223528 | log transformed data | Male | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.366060222 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.359645176 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.354055332 | log transformed data | Female | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.344242907 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.343929197 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.338928135 | log transformed data | Male | 2 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.334046541 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.330881887 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.330209932 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.322370758 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.321679639 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.319557969 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.31670885 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.314447681 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.310616758 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.308485716 | log transformed data | Male | 1 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.306408429 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.303843791 | log transformed data | Male | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.301179907 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.300801151 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.299577415 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.293979714 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.292518893 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.288286402 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.288262728 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.284101575 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.280532635 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.274644959 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.272493782 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.272142484 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.269464203 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.269414418 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.264709562 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.262142494 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.258744168 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.254569806 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.25452088 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.249833339 | log transformed data | Female | 1 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.249037922 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.247575142 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.247022513 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.24661972 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.245958365 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.245721109 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.244890998 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.244482693 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.244241219 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.24326933 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.238793052 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.238333746 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.236719758 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.236660479 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.235704227 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.235113756 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.234931835 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.233756277 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.232975262 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.23273047 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.23129257 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.229256935 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.228776585 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.228227039 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.226555819 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.226439861 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.221664053 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.221198535 | log transformed data | Female | 3 | Other | Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.220405934 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.220256935 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.219502127 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.217012833 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.216364162 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.214547312 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.213749417 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.211854868 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.210954156 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.208759557 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.208752286 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.208014971 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.20519879 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.202345003 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.199381338 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.198810664 | log transformed data | Male | 0 | White | Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.196737592 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.195945953 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.195036461 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.192768397 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.192355442 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.187896899 | log transformed data | Female | 3 | Black | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.186933609 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.18648603 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.18628492 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.185423638 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.184063537 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.180357908 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.18020452 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.177268063 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.17335443 | log transformed data | Female | 0 | Other | Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.172794951 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.171587029 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.170495147 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.165906246 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.165656932 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.165648695 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.164337332 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.163875878 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.159962718 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.15988362 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.158975324 | log transformed data | Male | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.158256777 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.157805016 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.157672513 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.157033848 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.155993163 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.15589093 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.154142249 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.152510388 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.151571141 | log transformed data | Female | 1 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.151503693 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.150513603 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.146893517 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.145333383 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.142594697 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.142460077 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.140024442 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.138445357 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.138043628 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.137826828 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.136854463 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.135230649 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.132589197 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.131943788 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.130445513 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.129412879 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.129366133 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.125976034 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.125969548 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.125391279 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.12503202 | log transformed data | Female | 1 | White | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.124787797 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.122495112 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.121117232 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.120850668 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.120803112 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.120348569 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.119708189 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.115952514 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.115522807 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.115212689 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.115082969 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.114981776 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.113251717 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.112389912 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.111863838 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.109486671 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.10789817 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | during COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.10720616 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.106908165 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.106530516 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.106415026 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.103679737 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.10304699 | log transformed data | Male | 1 | Other | Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.101161043 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.098975654 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.098497063 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.097957021 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.097641767 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.097074168 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.0968082 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.094118965 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.09406039 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.09241517 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.091354653 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.090643136 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | -0.090102114 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Return to search page
